Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.

NCT00282620 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Arrhythmia
Quality of Life
Hypomagnesemia

Interventions

DRUG: Magnesium L-lactate

Sponsor

Hartford Hospital